Methods and compositions involving polymeric immunoglobulin fusion proteins
US8163289B2 · kind B2 · utility
0Cited by
34References
97Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 6, 2008 |
| Grant date | Apr 24, 2012 |
| Priority date | — |
| Expiry date | Mar 6, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/14043
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns inventive polypeptides. The present invention also concerns compositions and vaccines comprising the inventive polypeptides. In other embodiments of the invention, the inventive polypeptides are provided to a subject, used to vaccinate, or used to induce immunity. Other embodiments include methods for making the inventive polypeptides and nucleic acids used to encode the inventive polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.